Drs Wallaert-Moerman
ActiveDrs Wallaert-Moerman has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €192k and a net result of €29k. Equity is growing by ~7.9% per year across the filed fiscal years. Its solvency ranks better than 91% of 16414 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
100
/ 100
Excellent▲ +9 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability76▲+76
Solvency100=
Growth52=
Stability100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €19k at 30 days acceptable
Liquidity ample (current ratio 17.82 against 4.85 in 2024), and 5.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
94.9%
Return on assets
14.5%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 28-01-2026, 3 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
3 d early
2024
1 d early
2023
6 d early
2022
1 d early
2021
3 d early
2020
1 d late
2019
18 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close15-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€192k▲ 1.5%
2024 · €189k
2019: €103k
2020: €131k
2021: €89k
2022: €218k
2023: €210k
2024: €189k
2019 → 2025
Total assets
€202k▼ 12.2%
2024 · €231k
2019: €173k
2020: €219k
2021: €150k
2022: €322k
2023: €244k
2024: €231k
2019 → 2025
Net result
€29k▲ 17,884%
2024 · €163
2019: €54k
2020: €28k
2021: €10k
2022: €130k
2023: €-8k
2024: €163
2019 → 2025
Working capital
€173k▲ 8.9%
2024 · €159k
2019: €66k
2020: €92k
2021: €57k
2022: €171k
2023: €170k
2024: €159k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€89k-€218k▲ 144%€210k▼ 3.8%€189k▼ 9.7%€192k▲ 1.5%
Operating result€16k-€189k▲ 1,092%€53k▼ 72.2%€48k▼ 8.7%€88k▲ 82.9%
Net result€10k-€130k▲ 1,241%€-8k€163€29k▲ 17,884%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 83% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €202k
Fixed assets
€19k▼ 36.8%
Current assets
€183k▼ 8.4%
Equity and liabilities €202k
Equity
€192k▲ 1.5%
Debt
€10k▼ 75.1%
The debt ratio falls from 17.9% to 5.1%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€107k▲
2024 · €69k
Cash flow
€49k▲
2024 · €22k
Solvency
94.9%▲
2024 · 82.1%
Current ratio
17.82▲
2024 · 4.85
Quick ratio
17.82▲
2024 · 4.85
Debt / equity
0.05▼
2024 · 0.22
ROE
15.2%▲
2024 · 0.1%
ROA
14.5%▲
2024 · 0.1%
Interest coverage
16.27▼
2024 · 128.15
Debt
€10k▼
2024 · €41k
Debt ≤ 1 year
€10k▼
2024 · €41k
Income taxes
€12k▲
2024 · €2k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€231k€202k▼
Fixed assets21/28€31k€19k▼
Tangible fixed assets22/27€28k€17k▼
Plant, machinery and equipment23€16k€17k▲
Furniture and vehicles24€13k€230▼
Financial fixed assets28€2k€2k=
Current assets29/58€200k€183k▼
Amounts receivable after more than one year29€40k€0▼
Trade receivables290€40k€0▼
Amounts receivable within one year40/41-€6k
Other amounts receivable41-€6k
Cash at bank and in hand54/58€152k€148k▼
Deferred charges and accrued income490/1€7k€29k▲
Equity and liabilities
Total equity and liabilities10/49€231k€202k▼
Equity10/15€189k€192k▲
Contributions10/11€4k€4k=
Reserves13€191k€189k▼
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€191k€189k▼
Profit (loss) carried forward14€-5k€0▲
Amounts payable17/49€41k€10k▼
Amounts payable after more than one year17€0-
Financial debts170/4€0-
Amounts payable within one year42/48€41k€10k▼
Current portion of amounts payable after more than one year42€12k€0▼
Trade debts44€8k€8k▲
Suppliers440/4€8k€8k▲
Taxes, remuneration and social security45€2k€2k▼
Taxes450/3€2k€2k▼
Other amounts payable47/48€18k€0▼
Income statement
Code20242025
Non-recurring operating income76A€28k€0▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€21k€19k▼
Other operating charges640/8€1k€2k▲
Gross operating margin9900€71k€109k▲
Operating profit (loss)9901€48k€88k▲
Financial income75/76B€0€150k▲
Recurring financial income75€0€150k▲
Non-recurring financial income76B-€150k
Financial charges65/66B€46k€197k▲
Recurring financial charges65€542€7k▲
Non-recurring financial charges66B€45k€190k▲
Profit (loss) for the period before taxes9903€2k€41k▲
Income taxes67/77€2k€12k▲
Profit (loss) for the period9904€163€29k▲
Profit (loss) for the period to be appropriated9905€163€29k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-7k€24k▲
Profit (loss) brought forward from the previous period14P€-8k€-5k▲
Transfer from equity791/2€22k€27k▲
Transfer to equity691/2-€24k
To other reserves6921-€24k
Profit to be distributed694/7€21k€27k▲
Return on contributions (dividend)694€21k€27k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial
Liquidity quadruplescurrent ratio 17.82
Current ratio from 4.85 to 17.82; short-term debt falls from €41k to €10k.
30-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-06
Financial
Back to profitnet €163
Net result €163 after one loss-making year.
25-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial
Weakest financial yearnet €-8k ▼106%
Net result drops to €-8k, the lowest in the series; recovery starts the following year.
30-06
Financial
Liquidity triplescurrent ratio 8.70
Current ratio from 3.16 to 8.70; short-term debt falls from €79k to €22k.
30-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
Financial
Highest result since 2019net €130k ▲1241%
Operating result €189k, net result €130k, both a record.
30-06
Financial
Equity above €200kEq €218k ▲144%
4 profitable years in a row build equity to €218k.
28-01
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
01-02
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 1 day late
2020
13-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
10-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
11-01
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
31-01
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Deinze · 1 establishment unit since 2005
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Stokstormestraat 109800 DeinzeGround area
5,952 m²
Building footprint
629 m²
Volume, LiDAR
2,627 m³
2 parcels, Flanders · tallest building 12.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Burgemeesterstraat 11, 9830 Sint-Martens-Latem
since 20052.282.726.041
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44054B0669/00N000 | Flanders | 5,762 m² | 1 · 440 m² | 7.8 m · 1 fl. |
| 44064A0248/00E000 | Flanders | 189 m² | 1 · 189 m² | 12.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dokter Siegfried Segaert, Dermatoloog
BE 0692.925.042
Tremelo · Eq €192k
M.K.A. Dr. WINDERICKX - Dr. VANHOVE
BE 0824.060.827
Antwerpen · Eq €192k
Maxime Bonnelance Ortho
BE 0739.548.487
La Hulpe · Eq €192k
DERMATOLOGIEPRAKTIJK DR. K. DEBUSSCHERE
BE 0476.552.189
Bekkevoort · Eq €192k
Dokter Liesbeth Vandermeeren
BE 0731.815.114
Zaventem · Eq €192k
Of 16,604 companies in sector 86220 we hold annual accounts for 7,961. 6,719 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded27-01-2005
Fiscal year end30-06
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 20 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.